Coronavirus Action Plan | Norton Way Peugeot | News

Norton Way Group Coronavirus Action Plan

We are pleased to announce that we can officially welcome you back to our dealership.

As per Government guidelines, as of Monday 1st June, our showroom is now open for sales and the service department is open to all customers.

The safety and well-being of our customers and colleagues remains our number one priority, so to ensure this, we have put procedures in place which include numerous social distancing and enhanced hygiene measures, new operating processes and the widespread introduction of personal protective equipment to ensure everyone’s safety.

We are advising that you avoid waiting times, so please book an appointment in advance to see your required department.

All customers who aren’t displaying COVID-19 symptoms can visit our dealerships for appointments, COVID-19 safe test drives and walk-in enquiries.


Face Coverings

In line with government guidance introduced from the 24th July 2020 it is now mandatory to wear a face covering in all shops.

In order to protect our Customers and staff when arriving for your appointment please bring a face covering to wear during your visit.

We thank you for your understanding and support.



Department Overview

All of our departments are available to phone on:

SALES: 01462 559 759

SERVICE: 01462 559 760

PARTS: 01462 559 758

Click here to view our latest opening times


Sales

Showrooms now open - contact our team today if you have any questions regarding vehicle sales.

Click here for more information about Sales

Service

Showrooms now open - contact our team today if you have any questions regarding vehicle sales.

Click here for more information about Servicing

Parts

All franchise approved parts are available to order and collect.

Norton Way Group - Covid-19 Risk Assessment

If you would like to learn in detail about the precautions and safety measures we have in place to keep our staff and customers safe, you can download and read our Risk Assessment below.

COVID-19 RISK ASSESSMENT